The GD40h is a combined glucose and I-ketone meter for Type I & II diabetics
Suitable for Type I & II diabetics
0-70% haematocrit range, largest range on the market
Exceeds EN ISO 15197:2015
Large, back lit display
Voice results for impaired hearing users (Universal tone technology)
Auto strip ejection
Suitable for neonatal, children, gestational and dialysis patients
0.5mcl sample and 5 second result
Compatible with Diasend
Free APP for Apple and Android, results automatically downloaded via Bluetooth
Two kinds of communication export, Wired and Bluetooth
Free meters, controls, batteries
Free training for clinical staff and patients
Free Surgery patient reviews
Connect other separate devices such as weight and BMI using the FORA W550 digital scales and BP results using the FORA P30 digital monitor
1. INTENDED USE CDV + CPV Ag Combined Rapid Test is a combined cassette to diagnose the presence of Canine Disteimper virus antigen and Canine Parvovirus antigen in dogâ??s secretions, serum or feces. Assay Time: 5 - 10 min Sample: Secretions, serum or feces 2. PRINCIPLE OF THE ASSAY CDV + CPV Ag Combined Rapid Test is based on sandwich lateral flow immunochromatographic assay. The test device has two testing windows. Each testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough CDV antigen or CPV antigen in the sample, a visible T band will appear in the corresponding testing window. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of CDV antigen or CPV antigen in the sample. 3. KIT COMPONENT - 10Ã?foil pouches each containing a cassette, pipette and desiccant - 10Ã?assay buffer tubes (0.7 mL each) - 10Ã?assay buffer tubes (1.0 mL each) - 20Ã?swab sticks - Product Manual
1. INTENDED USE FIV Ab + FeLV Ag Combined Rapid Test is a combined cassette to differentially diagnose the presence of Feline Immunodeficiency antibody and Feline Leukemia Virus antigen in catâ??s blood. Assay Time: 10-15 min Sample: serum, plasma or whole blood 2. PRINCIPLE OF THE ASSAY FIV Ab + FeLV Ag Combined Rapid Test is based on sandwich lateral flow immunochromatographic assay. The test device has two testing windows. Each testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough FIV antibody or FeLV antigen in the sample, a visible T band will appear in the corresponding testing window. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of FIV antibody or FeLV antigen in the sample. 3. KIT COMPONENT - 10Ã?foil pouches, each containing a cassette,pipette and desiccant - 10Ã?assay buffer tubes (0.5 mL each) - 10Ã?centrifugal tubes - Product Manual
MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.
PANCCHECK is a blood test solution that enables early diagnosis of pancreatic cancer with 94% accuracy is under development. PANCCHECK DEVELOPMENT PROCESS: While effective early diagnostic methods for pancreatic cancer are currently lacking, BERTIS is developing a technology that enables early diagnosis of pancreatic cancer with a small blood sample. Through research, we have identified 10 protein biomarkers as a diagnostic marker panel for pancreatic cancer. Following algorithm development and validation, we have uncovered a combination of markers that demonstrates a high accuracy of 98% and is applicable in clinical settings.
1. INTENDED USE CPV + CCV Ag Combined Test is a combined cassette to differentially diagnose the presence of Canine Parvovirus antigen and Canine Coronavirus antigen in dogâ??s feces or vomit. Assay Time: 5 -10 min Sample: Feces or vomit 2. PRINCIPLE OF THE ASSAY CPV + CCV Ag Combined Test is based on sandwich lateral flow immunochromatographic assay. The test device has two testing windows. Each testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough CPV antigen or CCV antigen in the sample, a visible T band will appear in the corresponding testing window. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of CPV antigen or CCV antigen in the sample. 3. KIT COMPONENT - 10Ã?foil pouches, each containing acassette, pipette and desiccant - 10Ã?assay buffer tubes (1.0 mL each) - 10Ã?swab sticks - Product Manual
General information One-step cdv + cpv ag combined rapid test is a combined cassette to diagnose the presence of canine disteimper virus antigen and canine parvovirus antigen in dog’s secretions, serum or feces. Sensitivity : cdv 100% cpv 99.3% Specificity :cdv 99.8% cpv 99.4% Specimen: secretions, serum or feces Reading timen:5-10 min
1. INTENDED USE CPV + CCV +Giardia Ag Triple Test is a combined cassette to differentially diagnose the presence of Canine Parvovirus antigen, Canine Coronavirus antigen and Giardia antigen in dogâ??s feces or vomit. Assay Time: 5-10 min Sample: Feces or vomit 2. PRINCIPLE OF THE ASSAY CPV + CCV + Giardia Ag Triple Test is based on sandwich lateral flow immunochromatographic assay. The test device has three testing windows. Each testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough CPV antigen, CCV antigen or Giardia antigen in the sample, a visible T band will appear in the corresponding testing window. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of CPV, CCV or Giardia antigen in the sample. 3. KIT COMPONENT - 10Ã?foil pouches, each containing onecassette and a desiccant - 10Ã?assay buffer tubes (1.0 mL each) - 10Ã?pipettes - 10Ã?swab sticks - Product Manual
After the virus infection, the antibody IgM appears and rises in the early stage, while antibody IgG appears and rises in the late stage. â?¢ By combining IgG and IgM, we can know if the body is infected and at which stage . the Kit inckude: Novel Coronavirus (2019-nCoV) IgG/IgM Test Kit (Colloidal Gold) â?¢ Transport or store at room temperature from 2 to 30°C â?¢ If individual pouch unopened, the kit can be stored for 12 months. â?¢ Once the individual pouch is opened, this test card should be used within 1 hour.
The Herpes Simplex Virus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgG antibodies to Herpes Simplex Virus (HSV) in human serum/plasma samples. HSV-1 is usually associated with infection in oropharyngeal area and eyes, while HSV-2 causes mostly genital and neonatal infections (5, 6), however, the tissue specificity is not absolute (7). HSV-2 can be isolated occasionally from the oropharynx and 5-10% of primary genital infections may be caused by HSV-1. Infants infected with HSV appear normal at birth, but almost invariably develop symptoms during the newborn period (5, 8, 9). Neonatal HSV infection may remain localized or become disseminated. Localized infection may involve one or a combination of sites. These are skin, eyes, mouth or the central nervous system. Disseminated infection is manifested by pneumonitis, hepatitis, disseminated intravascular coagulopathy and encephalitis. Of the infants with neonatal HSV, about one half of those surviving will develop severe neurological or ocular sequelae. A number of serological procedures have been developed to detect antibodies to HSV. These include complement fixation, indirect immunofluorescent antibody, plaque neutralization, and ELISA (6, 8, 10). Antibody of the IgG class is produced during the first 2-3 weeks of infection with HSV and exists only transiently in most patients. Serologic procedures, which measure the presence of IgG antibodies, help discriminate between primary and recurrent infections, since IgG antibodies is rarely found in recurrent infections. High affinity IgG antibodies to HSV, if present in a sample, may interfere with the detection of IgG specific antibody (9). High affinity IgG antibody may preferentially bind to HSV-1 antigen leading to false negative IgG results. Also, rheumatoid factor, if present, along with antigen specific IgG, may bind to IgG causing false positive IgG results. Both problems can be eliminated by deactivating IgG in the sample before testing for IgG.
